Burning Rock Biotech Limited
BNR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $50,715 | $70,423 | $161,255 | $630,841 |
| - Cash | $519,849 | $615,096 | $905,451 | $1,431,317 |
| + Debt | $52,321 | $12,324 | $50,787 | $86,685 |
| Enterprise Value | -$416,813 | -$532,349 | -$693,409 | -$713,791 |
| Revenue | $515,822 | $537,435 | $563,238 | $507,862 |
| % Growth | -4% | -4.6% | 10.9% | – |
| Gross Profit | $362,400 | $363,227 | $380,039 | $364,146 |
| % Margin | 70.3% | 67.6% | 67.5% | 71.7% |
| EBITDA | -$270,232 | -$517,901 | -$856,311 | -$746,496 |
| % Margin | -52.4% | -96.4% | -152% | -147% |
| Net Income | -$346,626 | -$653,689 | -$971,233 | -$796,697 |
| % Margin | -67.2% | -121.6% | -172.4% | -156.9% |
| EPS Diluted | -33.67 | -63.84 | -93.47 | -76.45 |
| % Growth | 47.3% | 31.7% | -22.3% | – |
| Operating Cash Flow | -$92,261 | -$255,783 | -$456,808 | -$477,886 |
| Capital Expenditures | -$5,977 | -$9,384 | -$62,031 | -$213,448 |
| Free Cash Flow | -$98,238 | -$265,167 | -$518,839 | -$691,334 |